These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36717652)

  • 1. Comparative analysis of the relationship between four hepatic steatosis indices and muscle mass.
    Lee T; Chung TH
    Sci Rep; 2023 Jan; 13(1):1645. PubMed ID: 36717652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
    Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.
    Wang C; Cai Z; Deng X; Li H; Zhao Z; Guo C; Zhang P; Li L; Gu T; Yang L; Zhao L; Wang D; Yuan G
    Int J Med Sci; 2021; 18(14):3280-3289. PubMed ID: 34400897
    [No Abstract]   [Full Text] [Related]  

  • 4. Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).
    Hong KS; Kim MC; Ahn JH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1005-1014. PubMed ID: 32440112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
    Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
    Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
    J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease.
    Jo IH; Song DS; Chang UI; Yang JM
    Sci Rep; 2023 Apr; 13(1):6920. PubMed ID: 37117864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study.
    Roh E; Hwang SY; Yoo HJ; Baik SH; Lee JH; Son SJ; Kim HJ; Park YS; Lee SG; Cho BL; Jang HC; Kim BJ; Kim M; Won CW; Choi KM
    Hepatol Int; 2022 Jun; 16(3):545-554. PubMed ID: 34780030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008-2011).
    Kim HM; Lee YH
    Endocrinol Metab (Seoul); 2021 Dec; 36(6):1232-1242. PubMed ID: 34809412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity.
    Han E; Kim MK; Im SS; Jang BK; Kim HS
    J Diabetes Complications; 2022 Aug; 36(8):108253. PubMed ID: 35817677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
    Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
    J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population.
    Lind L; Johansson L; Ahlström H; Eriksson JW; Larsson A; Risérus U; Kullberg J; Oscarsson J
    World J Hepatol; 2020 Apr; 12(4):149-159. PubMed ID: 32685107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
    Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
    Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study.
    Son DH; Kwon YJ; Lee JH
    J Nutr Health Aging; 2024 Jun; 28(6):100270. PubMed ID: 38833877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of five hepatic steatosis algorithms in metabolic-associated fatty liver disease: A population based study.
    Liu Y; Liu S; Huang J; Zhu Y; Lin S
    J Gastroenterol Hepatol; 2022 May; 37(5):938-945. PubMed ID: 35174539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Dietary Sodium Intake Assessed by Estimated 24-h Urinary Sodium Excretion Is Associated with NAFLD and Hepatic Fibrosis.
    Huh JH; Lee KJ; Lim JS; Lee MY; Park HJ; Kim MY; Kim JW; Chung CH; Shin JY; Kim HS; Kwon SO; Baik SK
    PLoS One; 2015; 10(11):e0143222. PubMed ID: 26571018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies].
    Nosov AE; Zenina MT; Gorbushina OY; Baidina AS; Vlasova EM; Alekseev VB
    Ter Arkh; 2021 Aug; 93(8):883-889. PubMed ID: 36286882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.
    Hashimoto Y; Osaka T; Fukuda T; Tanaka M; Yamazaki M; Fukui M
    Endocr J; 2016 Oct; 63(10):877-884. PubMed ID: 27397679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.